Company · Healthcare

Genetic Signatures

Develops PCR-based infectious disease tests under its EasyScreen brand

North Ryde, NSW

Investor	Rounds	Invested
No investors recorded yet. Know one?

What Genetic Signatures bought

Companies Genetic Signatures acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
Genetic Signatures is not recorded as having acquired anything.

Name	Role	Sources
Allison Rossiter	CEO	@AuManufacturing
Stéphane Chatonsky	Non-executive Director	@AuManufacturing

Coverage

Stories naming Genetic Signatures. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

15 deals

🇦🇺 This Week in Australian Startups #179, 26th September 2026

Weekly roundup recording a dozen raises and acquisitions, Firmus's scheduled float, a new $50m venture fund, a founder share sale, grant winners, an accelerator intake, and an AI agent's government breach.

This Week in Australian Startups 26 Sep 2026 Amber Electric Auric CodeBreakers Fever Heidi Health HEO Hubblenetwork Kinoxis Therapeutics Medcast OpenDebt Remagine Labs RentBetter Significant Capital Ventures TasTest Zeligate Advanced Navigation Afterpay Airtasker AirTrunk Airwallex Anthropic AUSTRAC Australian Government Australian Signals Directorate Catch CDC Centre Droneshield Elixinol Wellness Ellerston Capital Employment Hero Firmus Technologies Genetic Signatures Innovaero Investment NSW Kongsberg Luxury Escapes Medicare Microba Morgan Stanley National Transport Solutions Nearmap News Corp NSW Government Ofload OpenAI ParaScript Ramp South Australian Government Spark Stakk Limited Telix Pharmaceuticals Telstra The U Group Thoma Bravo University of Canberra University of Newcastle Victoria Vitable 1GT AirTree Ventures Angel Investors Antler Australia Athletic Ventures Avicella Capital Baillie Gifford Beaten Zone Venture Partners Best Practice Blackbird Ventures Carthona Capital CSIRO DCode Capital Deepwater Dumm Capital E.ON EQT ETF Partners EVP General Catalyst Headline Innovation Victoria Main Sequence Ventures Medical Research Future Fund Monash University NRF Corporation Paspalis Phoenix Court Point72 Salus Ventures Scalare Partners Stoic Venture Capital Ten13 Uniseed UniSuper University of Sydney UNSW Greg Boorer Pat Cummins Sam Kerr Albanese Anoulack Chanthivong Gabby Leibovich Hezi Leibovich Jack Zhang Jonathan Lui

Also Dynamic Business·DealStreetAsia·This Week in Australian Startups·Dealroom·ABC News Technology

Funding announcement

Three's a party! Medtech BCAL woos Genetic Signatures, Sonic's Microba

Street Talk reports BCAL Diagnostics' takeover plan for Genetic Signatures collapsed once the target's talks with Sonic-backed Microba surfaced, with a three-company combination now under discussion.

AFR Technology 9 Sep 2026 BCAL Genetic Signatures Microba Life Sciences Sonic Healthcare

News